Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 4,495 | 2,903 | 1,929 | 2,047 | 3,302 |
| Cost of Goods | 1,438 | 787 | 639 | 687 | 2,346 |
| Gross Profit | 3,057 | 2,116 | 1,290 | 1,360 | 956 |
| Operating Expenses | 6,376 | 5,061 | 5,346 | 7,007 | 4,241 |
| Operating Income | -2,881 | -2,158 | -3,417 | -4,960 | -2,939 |
| Interest Expense | 24 | 6 | 5 | 18 | 158 |
| Other Income | 106 | 105 | 142 | -522 | 131 |
| Pre-tax Income | -2,799 | -2,059 | -3,280 | -5,500 | -2,966 |
| Net Income Continuous | -2,799 | -2,059 | -3,280 | -5,500 | -2,966 |
| Net Income | $-2,799 | $-2,059 | $-3,280 | $-5,500 | $-2,966 |
| EPS Basic Total Ops | -0.19 | -0.14 | -0.23 | -0.39 | -0.21 |
| EPS Basic Continuous Ops | -0.19 | -0.14 | -0.23 | -0.39 | -0.21 |
| EPS Diluted Total Ops | -0.19 | -0.14 | -0.23 | -0.39 | -0.21 |
| EPS Diluted Continuous Ops | -0.19 | -0.14 | -0.23 | -0.39 | -0.21 |
| EBITDA(a) | $-3,042 | $-2,150 | $-3,391 | $-4,878 | $-2,540 |